Scinovex
article Open Access

Amniotic membrane use for resistant infectious and non-infectious corneal ulcer

International Journal of Medical Ophthalmology · 2023 · Vol. 5(2) · pp. 31–34
Ahmed Mohammed Sameh El-ShorbagyWaleed Abd Elhady AllamGamal M. El MaghrabyOsama El-Saied ShalabyAdel Abdou Selima

Abstract

In corneal ulcers, amniotic membrane (AM) is utilised for supporting damaged tissues, shield and protect deficiencies from further deterioration or breakdown from external influences and encourage re-cellularization of the cornea. Anti-fibrotic, anti-inflammatory, and anti-angiogenic effects, as well as an antimicrobial impact and the encouragement of epithelial and stromal repair are some of the qualities possessed by amniotic membrane. Surgical grafting to the ocular surface, non-surgical patching with a carriage device, amniotic membrane extract eye drops (AMEED), amniotic membrane with umbilical cord blood, and amniotic membrane with placental fluid are certain uses and techniques for utilising AM in corneal ulcers and corneal epithelial deficiencies.

Corneal Surgery and TreatmentsCorneaMedicinecorneal ulcerUmbilical cordAmniotic fluidAmnionCorneal epitheliumAntimicrobialOphthalmologyImmunology
Citations
0
FWCI
0.00
field-weighted impact
References
21
Percentile
31%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Amniotic membrane use for resistant infectious and non-infectious corneal ulcer · Scinovex